Institutional Biosafety Committee – IBC
The Institutional Biosafety Committee (IBC) was established to review research and teaching activities that involve recombinant or synthetic-nucleic acids (r-sDNA), biological agents or toxins. The purpose of the review process is to ensure the University activities comply with government regulations and provide appropriate safeguards for human health and the environment.
The IBC oversight process is based on the requirement that all biological research that falls within the committee's purview is registered, reviewed, and approved on a recurring basis at meetings of the IBC. The IBC review and approval process is based on the completion and submission of the IBC Registration form to the IBC Office. The EHS, Manager of Biological Health & Safety serves as the Institutional Biosafety Officer (IBSO) and Select Agent Responsible Official (RO).
The IBC provides guidance on research safety issues as described in the NIH Guidelines (Section IV-B-2-b). For example, the IBC will assess facilities, incidents, procedures, practices, training and expertise of personnel involved with r-sDNA research. The IBC will ensure compliance with all necessary health surveillance, data reporting, and adverse event reporting requirements. The IBC also works to ensure compliance with other relevant state and federal regulations.